Skip to main content
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T
Published Web Location
http://europepmc.org/articles/PMC4160816?pdf=renderNo data is associated with this publication.
Abstract
Background:Sipuleucel-T has demonstrated improved overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC). This analysis examined the effect of sipuleucel-T on time to disease-related pain (TDRP) and time to first use of o
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.